Bioquivalence of ciprofloxacin tablet formulations assessed in Indonesian volunteers

International Journal of Clinical Pharmacology and Therapeutics

Volumn 45, Issue 6, 2007, Pages 373-376

  Harahap, Yahdiana ^a   Prasaja, B ^b   Indriati, E ^b   Lusthom, W ^b   Lipin, ^b  

^a UNIVERSITY OF INDONESIA   (Indonesia)

^b Clinisindo Laboratories   (Indonesia)

Author keywords

Bioequivalence; Ciprofloxacin; Pharmacokinetics

Indexed keywords

CIPROFLOXACIN; ANTIINFECTIVE AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REGIMEN; DRUG FORMULATION; FEMALE; FOOD AND DRUG ADMINISTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INDONESIA; MALE; NORMAL HUMAN; TABLET; VOLUNTEER; ADOLESCENT; CHEMISTRY; HALF LIFE TIME; PHARMACOKINETICS; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; CROSS-OVER STUDIES; FEMALE; HALF-LIFE; HUMANS; INDONESIA; MALE; TABLETS; THERAPEUTIC EQUIVALENCY;

EID: 34250190274     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/cpp45373     Document Type: Article

References (8)

1. Colino, CI, Garcia TA, Sanches NA, Lanao JM. A comparative study of ofloxacin and ciprofloxacin erythrocyte distribution. Biopharm Drug Dispos. 1998; 19: 71-77.
2. CPMP Committee for Proprietary Medicinal Products. Note for guidance on the investigation of bioavailability and bioequivalence. The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit. 2001; (CPMP/EWP/QWP/1401/98).
3. Craig WA. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis. 1995; 22: 88-96.
4. Cuadrado A, Gascon AR, Solinis MA, Ramirez E, Hernandez RM, Knie U, Pedraz JL. Bioequivalence of two oral ciprofloxacin tablets formulation. Int J Clin Pharmacol Ther. 2004; 42: 336-341.
5. Diletti E, Hauschke D, Steinijans VW. Sample size determination for bioequivalence assessment by means of confidence intervals. Int J Clin Ther Toxicol. 1991; 29: 1-8.
6. FDA Food and Drug Administration. Guidance for industry: bioanalytical methods validation. Rockville, MD, USA: Centre for Drug Evaluation and Research; 2001.
7. Moffat AC, Osselton MD, Widdop B. Clarke's analysis of drugs and poisons in Pharmaceuticals, body fluids and postmortem material (3rd ed). London: Pharmaceutical Press. 2004; 808-810.
8. Shah VP, Midha KK, Findlay JWA, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A. Bioanalytical method validation. A revisit with a decade of progress. Workshop/Conference Report Pharm Res. 2000; 17: 1551-1557.